Medicinal Preparations [2026-2029] Tender - 137710635

Procurement Summary

Country: Czech Republic

Summary: Medicinal Preparations [2026-2029]

Deadline: 13 Apr 2026

Posting Date: 13 Mar 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 137710635

Document Ref. No.: 174505-2026

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: CZK 7950000

CPV Classification

33600000 - Pharmaceutical products

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

The subject of the public contract is the supply of medicinal products according to the specifications and under the conditions specified in Annexes No. 2 (Specification of individual parts of the public contract) and No. 3 (Sample of the purchase contract) of the procurement documentation. Lenvatinib ATC Active ingredient Strength and medicinal form Package size Unit of measure Number of units L01EX08 Lenvatinib* 10 MG CPS DUR 30 CPS packaging 600 L01EX08 Lenvatinib* 4 MG CPS DUR 30 CPS packaging 400 *The contracting authority requests the supply of a medicinal product with an indication for kidney cancer. Pembrolizumab ATC Effective substance Strength and dosage form Package size Unit of measure Number of units L01FF02 Pembrolizumab 25 MG/ML INF CNC SOL 1×4ML packaging 15000 Ribociclib ATC Active ingredient Strength and dosage form Package size Unit of measure Number of units L01EF02 Ribociclib 200 MG TBL FLM 42 TB packaging 3000 Mirvetuximab soravtansin ATC Active ingredient Strength and dosage form Package size Unit of measure Number of units L01FX26 Mirvetuximab soravtansin 5 MG/ML INF CNC SOL 1×20ML packaging 800 Belzutifan ATC Active ingredient Strength and dosage form Size packaging Unit of measure Number of units L01X74 Belzutifan 40MG TBL FLM 90(3X30) 90 TB packaging 200 Cetuximab ATC Active ingredient Strength and dosage form Package size Unit of measure Number of units L01FE01 Cetuximab 5 MG/ML INF SALT 1x100ML packaging 3700 Ipilimumab ATC Active ingredient Strength and dosage form Package size Unit of measure Number of units L01FX04 Ipilimumab 5 MG/ML INF CNC SOL 1×10ML packaging 1200 Tebentafusp ATC Active ingredient Strength and dosage form Package size Measurable is...
Document Type: Contract Notice Reference Number: MOU 560 831 Contract Type: supplies Estimated Value: 7950000 - CZK Authority Type: body-pl-cga Doc Title: Léčivé přípravky [2026–2029] Dispatch Date: 2026-03-12 Publish Date: 2026-03-13 Submission Date: 2026-04-13

Documents

 Tender Notice